The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions
- Autores
- Mattiazzi, Alicia Ramona; Mundiña-Weilenmann, Cecilia; Vittone, Leticia; Said, María Matilde; Kranias, E. G.
- Año de publicación
- 2006
- Idioma
- inglés
- Tipo de recurso
- reseña artículo
- Estado
- versión publicada
- Descripción
- The sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser16 site by PKA or the Thr17 site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca2+ uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca2+ load and myocardial contractility. In the intact heart, β-adrenoceptor stimulation results in phosphorylation of PLN at both Ser16 and Thr17 residues. Phosphorylation of the Thr17 residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by β-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca2+, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr17 residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca2+ and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr17 at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr17 mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr17 residue of PLN probably participates in a protective mechanism that favors Ca2+ handling and limits intracellular Ca2+ overload in pathological situations.
Facultad de Ciencias Médicas - Materia
-
Ciencias Médicas
isoprenaline
β-adrenergic stimulation
acidosis
ischemia
serine
threonine
phospholamban
Thr17 site phosphorylation
hypercapnia
pathophysiology
physiology - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by-nc/3.0/
- Repositorio
- Institución
- Universidad Nacional de La Plata
- OAI Identificador
- oai:sedici.unlp.edu.ar:10915/37573
Ver los metadatos del registro completo
id |
SEDICI_2caa8ba35432335a9dfa0e0371aea3f2 |
---|---|
oai_identifier_str |
oai:sedici.unlp.edu.ar:10915/37573 |
network_acronym_str |
SEDICI |
repository_id_str |
1329 |
network_name_str |
SEDICI (UNLP) |
spelling |
The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditionsMattiazzi, Alicia RamonaMundiña-Weilenmann, CeciliaVittone, LeticiaSaid, María MatildeKranias, E. G.Ciencias Médicasisoprenalineβ-adrenergic stimulationacidosisischemiaserinethreoninephospholambanThr17 site phosphorylationhypercapniapathophysiologyphysiologyThe sarcoplasmic reticulum (SR) Ca<SUP>2+</SUP>-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser<SUP>16</SUP> site by PKA or the Thr<SUP>17</SUP> site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca<SUP>2+</SUP> uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca<SUP>2+</SUP> load and myocardial contractility. In the intact heart, β-adrenoceptor stimulation results in phosphorylation of PLN at both Ser<SUP>16</SUP> and Thr<SUP>17</SUP> residues. Phosphorylation of the Thr<SUP>17</SUP> residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by β-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca<SUP>2+</SUP>, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr<SUP>17</SUP> residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca<SUP>2+</SUP> and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr<SUP>17</SUP> at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr<SUP>17</SUP> mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr<SUP>17</SUP> residue of PLN probably participates in a protective mechanism that favors Ca<SUP>2+</SUP> handling and limits intracellular Ca<SUP>2+</SUP> overload in pathological situations.Facultad de Ciencias Médicas2006-05info:eu-repo/semantics/reviewinfo:eu-repo/semantics/publishedVersionRevisionhttp://purl.org/coar/resource_type/c_dcae04bcinfo:ar-repo/semantics/resenaArticuloapplication/pdf563-572http://sedici.unlp.edu.ar/handle/10915/37573enginfo:eu-repo/semantics/altIdentifier/url/http://www.scielo.br/pdf/bjmbr/v39n5/6159.pdfinfo:eu-repo/semantics/altIdentifier/issn/0100-879Xinfo:eu-repo/semantics/altIdentifier/doi/10.1590/S0100-879X2006000500001info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc/3.0/Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-29T10:57:03Zoai:sedici.unlp.edu.ar:10915/37573Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-29 10:57:04.193SEDICI (UNLP) - Universidad Nacional de La Platafalse |
dc.title.none.fl_str_mv |
The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions |
title |
The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions |
spellingShingle |
The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions Mattiazzi, Alicia Ramona Ciencias Médicas isoprenaline β-adrenergic stimulation acidosis ischemia serine threonine phospholamban Thr17 site phosphorylation hypercapnia pathophysiology physiology |
title_short |
The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions |
title_full |
The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions |
title_fullStr |
The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions |
title_full_unstemmed |
The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions |
title_sort |
The importance of the Thr<SUP>17</SUP> residue of phospholamban as a phosphorylation site under physiological and pathological conditions |
dc.creator.none.fl_str_mv |
Mattiazzi, Alicia Ramona Mundiña-Weilenmann, Cecilia Vittone, Leticia Said, María Matilde Kranias, E. G. |
author |
Mattiazzi, Alicia Ramona |
author_facet |
Mattiazzi, Alicia Ramona Mundiña-Weilenmann, Cecilia Vittone, Leticia Said, María Matilde Kranias, E. G. |
author_role |
author |
author2 |
Mundiña-Weilenmann, Cecilia Vittone, Leticia Said, María Matilde Kranias, E. G. |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
Ciencias Médicas isoprenaline β-adrenergic stimulation acidosis ischemia serine threonine phospholamban Thr17 site phosphorylation hypercapnia pathophysiology physiology |
topic |
Ciencias Médicas isoprenaline β-adrenergic stimulation acidosis ischemia serine threonine phospholamban Thr17 site phosphorylation hypercapnia pathophysiology physiology |
dc.description.none.fl_txt_mv |
The sarcoplasmic reticulum (SR) Ca<SUP>2+</SUP>-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser<SUP>16</SUP> site by PKA or the Thr<SUP>17</SUP> site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca<SUP>2+</SUP> uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca<SUP>2+</SUP> load and myocardial contractility. In the intact heart, β-adrenoceptor stimulation results in phosphorylation of PLN at both Ser<SUP>16</SUP> and Thr<SUP>17</SUP> residues. Phosphorylation of the Thr<SUP>17</SUP> residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by β-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca<SUP>2+</SUP>, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr<SUP>17</SUP> residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca<SUP>2+</SUP> and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr<SUP>17</SUP> at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr<SUP>17</SUP> mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr<SUP>17</SUP> residue of PLN probably participates in a protective mechanism that favors Ca<SUP>2+</SUP> handling and limits intracellular Ca<SUP>2+</SUP> overload in pathological situations. Facultad de Ciencias Médicas |
description |
The sarcoplasmic reticulum (SR) Ca<SUP>2+</SUP>-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser<SUP>16</SUP> site by PKA or the Thr<SUP>17</SUP> site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca<SUP>2+</SUP> uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca<SUP>2+</SUP> load and myocardial contractility. In the intact heart, β-adrenoceptor stimulation results in phosphorylation of PLN at both Ser<SUP>16</SUP> and Thr<SUP>17</SUP> residues. Phosphorylation of the Thr<SUP>17</SUP> residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by β-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca<SUP>2+</SUP>, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr<SUP>17</SUP> residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca<SUP>2+</SUP> and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr<SUP>17</SUP> at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr<SUP>17</SUP> mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr<SUP>17</SUP> residue of PLN probably participates in a protective mechanism that favors Ca<SUP>2+</SUP> handling and limits intracellular Ca<SUP>2+</SUP> overload in pathological situations. |
publishDate |
2006 |
dc.date.none.fl_str_mv |
2006-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/review info:eu-repo/semantics/publishedVersion Revision http://purl.org/coar/resource_type/c_dcae04bc info:ar-repo/semantics/resenaArticulo |
format |
review |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://sedici.unlp.edu.ar/handle/10915/37573 |
url |
http://sedici.unlp.edu.ar/handle/10915/37573 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.scielo.br/pdf/bjmbr/v39n5/6159.pdf info:eu-repo/semantics/altIdentifier/issn/0100-879X info:eu-repo/semantics/altIdentifier/doi/10.1590/S0100-879X2006000500001 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc/3.0/ Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0) |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc/3.0/ Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0) |
dc.format.none.fl_str_mv |
application/pdf 563-572 |
dc.source.none.fl_str_mv |
reponame:SEDICI (UNLP) instname:Universidad Nacional de La Plata instacron:UNLP |
reponame_str |
SEDICI (UNLP) |
collection |
SEDICI (UNLP) |
instname_str |
Universidad Nacional de La Plata |
instacron_str |
UNLP |
institution |
UNLP |
repository.name.fl_str_mv |
SEDICI (UNLP) - Universidad Nacional de La Plata |
repository.mail.fl_str_mv |
alira@sedici.unlp.edu.ar |
_version_ |
1844615831793696768 |
score |
13.070432 |